# AtlantiCare account plan

> AtlantiCare is a non-profit health system in southern New Jersey with a 593-bed regional medical center and $1,318.7 million of 2025 revenue.

## At a glance

AtlantiCare Health System is an independent non-profit integrated health system serving southeastern New Jersey. It runs AtlantiCare Regional Medical Center (593 licensed beds across the City Campus in Atlantic City and the Mainland Campus in Pomona), a multispecialty physician group, behavioral health services, ambulatory surgery centers, a captive insurer and an accountable care organization, with more than 100 locations. In FY2025 (year to December 31, 2025) total revenue was $1,318.7 million (2024: $1,238.5 million) and operations returned to a $7.6 million operating income from a $15.2 million loss; investment gains lifted the excess of revenue over expenses to $172.2 million. All operations are in New Jersey and most entities are Section 501(c)(3) organizations.

## Business units

- **AtlantiCare Regional Medical Center** (about 75% of FY2025 net patient service revenue ($947.6 million)): The acute-care hospital, with 593 licensed beds on the City Campus in Atlantic City and the Mainland Campus in Pomona. It earned $27.9 million from operations in FY2025 and $10.7 million in the six months to June 30, 2026, and holds most of the group's investments.
- **AtlantiCare Physician Group** (about 13% of FY2025 net patient service revenue ($166.1 million)): A multispecialty physician group controlled by AtlantiCare. It lost $25.8 million from operations in 2025, offset by transfers from affiliates.
- **AtlantiCare Health Services** (about 6% of FY2025 net patient service revenue ($71.1 million)): Runs health and clinical support programs including a medically integrated fitness center, leases surgical and medical office suites, and holds the 49% interest in Osprey Rehabilitation (outpatient clinics and an inpatient rehabilitation facility). It lost $8.7 million from operations in 2025.
- **AtlantiCare Surgery Center** (about 5% of FY2025 net patient service revenue ($62.1 million)): Freestanding ambulatory surgical centers in Atlantic, Cape May and Ocean Counties, partly owned by outside holders, with $9.0 million of income from operations in 2025.
- **AtlantiCare Behavioral Health** (about 1% of FY2025 net patient service revenue ($13.7 million)): Outpatient mental health, addiction recovery and family care services for residents of southeastern New Jersey; loss from operations of $1.5 million in 2025.
- **English Creek Assurance**: A Bermuda-domiciled captive insurer providing hospital and provider professional liability and general liability coverage, with total revenue of $8.6 million in 2025.
- **AtlantiCare Health Solutions**: A for-profit accountable care organization with total revenue of $11.3 million in 2025; group-wide shared savings and ACO gains were $11.9 million.

## Strategic priorities

- **Vision 2030**: The plan launched by CEO Michael Charlton combines the Oracle technology overhaul, the Cleveland Clinic cancer affiliation, a medical school with Drexel University College of Medicine and Stockton University, and a main-campus expansion.
- **Oracle enterprise platform**: An EHR, revenue cycle and ERP platform expected to cost about $85 million, $36.6 million spent through 2025, with modules going live from mid-2025 through 2026.
- **Main campus expansion**: A new cardiac tower, emergency department and post-acute rehabilitation center; construction in progress stood at $65.0 million at end-2025 with about $55.0 million left to complete.
- **Medical school and workforce**: The new medical school is expected to be ready in January 2029; AtlantiCare University trains staff where shortages exist, and first-year nurse retention is 98%.
- **Oncology through Cleveland Clinic**: The Cleveland Clinic affiliation gives access to its procedures, protocols and tumor boards and helps recruit physicians and keep patients from going to Philadelphia hospitals.

## Latest results

The latest figures cover AtlantiCare Regional Medical Center only: in the six months to June 30, 2026 it reported total operating revenues of $515.6 million and income from operations of $10.7 million on expenses of $505.0 million. Investment return of $81.1 million lifted the excess of revenues over expenses to $96.4 million, and State of New Jersey subsidies contributed $65.3 million. Cash rose to $48.0 million from $21.4 million at December 2025. The statements give no prior-year comparison for the half and no guidance.

## Investments and deals

- **Oracle EHR, revenue cycle and ERP**: Contracted in late 2024 at an expected cost of about $85 million; the CEO described almost $100 million invested to overhaul the system's IT.
- **Capital expenditure**: Purchases of property and equipment of $80.2 million in FY2025 (2024: $78.6 million).
- **Osprey Rehabilitation joint venture**: A 49% stake in Osprey Rehabilitation, which took a $50.0 million bank term loan in 2025 guaranteed by its members; unconsolidated JV investments rose to $61.4 million from $13.0 million.
- **AI clinical documentation**: Early use of Oracle's AI documentation for primary care physicians cut documentation time by more than 40%; nursing units expect 40% to 50% reductions.

## Challenges and risks

- **Medicaid exposure**: About 40% of patients rely on Medicaid, and the CEO worries about looming Medicaid reductions; Medicaid accounted for $246.7 million of FY2025 net patient service revenue.
- **Thin operating margins**: FY2025 operating income was $7.6 million on $1,318.7 million of revenue, with most of the surplus coming from $161.1 million of investment gains.
- **Loss-making physician group**: The physician group lost $25.8 million from operations in 2025, and salaries and benefits of $781.5 million are the largest cost line.
- **Dependence on state payment programs**: New Jersey's County Option Hospital Fee Program contributed $98.9 million of FY2025 revenue, and State Directed Payments for part of state fiscal year 2026 await Federal approval.
- **Liability and payor settlements**: Professional liability net loss accruals were $35.5 million, and cost report settlements remain open to audit.

## What leadership says

> "the funding mechanism for all of health care is broken" — Michael Charlton, President and CEO, Chief Healthcare Executive interview, September 16, 2025

> "What we've said to our board is we're not going to be a first mover. We're going to watch this play out a little bit, and then we'll be a quick second mover when we know its impact." — Michael Charlton, President and CEO, SJ Magazine Hospital CEO Roundtable 2025, December 1, 2025, on AI

> "I think Vision 2030 has really redefined the purpose of this organization, and we've seen a significant decline in people that are leaving the organization" — Michael Charlton, President and CEO, Chief Healthcare Executive interview, September 16, 2025

> "The biggest secret weapon that AtlantiCare has is we're a health system that owns a federally qualified health center (FQHC)" — Michael Charlton, President and CEO, SJ Magazine Hospital CEO Roundtable 2025, December 1, 2025


## Where a supplier can help

- **Oracle roll-out services**: Tied to the Oracle platform priority: with modules going live through 2026, integration, training, data migration and revenue-cycle optimisation services have a clear window.
- **Construction and medical equipment**: Tied to the main campus expansion: the cardiac tower, emergency department and rehabilitation center need contractors, equipment and fit-out suppliers.
- **Physician group productivity**: Tied to the loss-making physician group and thin margins: staffing efficiency, scheduling and documentation tools address the dominant labor cost.
- **Proven clinical AI**: Tied to the documentation-time results and the CEO's quick-second-mover stance: AI tools with measured outcomes on Oracle Health fit better than unproven pilots.
- **Medicaid and supplemental payment support**: Tied to the Medicaid exposure challenge: revenue integrity, eligibility and state program reporting services help protect reimbursement.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [AtlantiCare Health System, Inc. and Affiliates — Consolidated Financial Statements and Supplementary Information, 2025](https://www.atlanticare.org/sites/default/files/pdf/2026%20-%20Financials/2025%20AtlantiCare%20Health%20System-%20Inc.%20and%20Affiliates%20AFS.pdf)

Annual report · 2026-05-18

- AtlantiCare Health System is an independent non-profit health system in southern New Jersey: AtlantiCare Regional Medical Center (593 licensed beds, City Campus in Atlantic City and Mainland Campus in Pomona), a multispecialty physician group, behavioral health, ambulatory surgery centers, a captive insurer and an accountable care organization.
- FY2025 (year to Dec 31, 2025) total revenue was $1,318.7 million (2024: $1,238.5 million); net patient service revenue $1,260.5 million, of which hospital and ambulatory facilities $1,017.7 million and physician services $242.8 million.
- Operations swung to a $7.6 million operating income from a $15.2 million operating loss in 2024; investment gains of $161.1 million lifted the excess of revenue over expenses to $172.2 million.
- Payor mix of net patient service revenue: commercial carriers $599.0 million, Medicare $406.7 million, Medicaid $246.7 million, self-pay $8.0 million; New Jersey's County Option Hospital Fee Program contributed $98.9 million of revenue against $32.8 million of fees.
- Salaries and benefits of $781.5 million are the largest cost line; the physician group lost $25.8 million from operations while the medical center earned $27.9 million.
- Balance sheet: investments of $1,132.1 million, long-term debt of $278.4 million (Series 2021 and 2023 NJHCFFA revenue bonds), net assets of $1,671.5 million; covenants met.
- Biggest IT program: an Oracle enterprise platform (EHR, revenue cycle, ERP) expected to cost about $85 million, $36.6 million spent through 2025, with modules going live from mid-2025 through 2026.
- Capex (purchases of property and equipment) was $80.2 million; construction in progress of $65.0 million with about $55.0 million left to complete; a 49% stake in Osprey Rehabilitation JV (inpatient rehab and outpatient clinics) with a guaranteed $50.0 million term loan.
- Risks named: Medicare/Medicaid payment cuts and pending federal approval of State Directed Payments, third-party payor settlements, professional liability claims ($35.5 million accrued) and investment market volatility.

### [AtlantiCare Regional Medical Center — Unaudited Financial Statements, six months ended June 30, 2026](https://www.atlanticare.org/sites/default/files/pdf/2026%20-%20Financials/2026%20Q2%20Unaudited%20Financial%20Statement.pdf)

Interim report

- Unaudited statements of AtlantiCare Regional Medical Center (the hospital entity, not the whole system) for the six months to June 30, 2026.
- Total operating revenues $515.6 million; net patient services revenue $506.8 million after $1,634.2 million of allowances on $2,164.2 million of gross charges.
- Income from operations $10.7 million on total expenses of $505.0 million.
- Investment return of $81.1 million lifted the excess of revenues over expenses to $96.4 million.
- State of New Jersey subsidies contributed $65.3 million in the half; charity and indigent care deductions were $72.4 million.
- Cash rose to $48.0 million from $21.4 million at December 2025; long-term investments $969.6 million; total net assets $1,368.0 million.
- Accounts payable fell to $10.3 million from $33.4 million; accrued pension liability dropped to $1.1 million from $4.6 million.
- Two hospital licenses reported: No. 641 with $314.3 million of operating revenue and No. 642 with $201.4 million.

### [AtlantiCare CEO touts progress on Vision 2030 and tackling big problems (Chief Healthcare Executive)](https://www.chiefhealthcareexecutive.com/view/atlanticcare-ceo-touts-progress-on-vision-2030-and-tackling-big-problems)

Executive talk · Michael Charlton, President and CEO · 2025-09-16

- Michael Charlton, president and CEO since October 2023, says AtlantiCare is "right on track" on Vision 2030, the plan he launched a little over a year before this September 2025 interview.
- The system runs two hospitals with about 600 beds and more than 100 locations across southern New Jersey.
- Oracle is "probably the biggest initiative that AtlantiCare has ever had": almost $100 million invested to overhaul the system's IT.
- Early AI clinical documentation for primary care physicians cuts documentation time by more than 40%, saving 90 minutes to two hours a day; nursing units expect 40% to 50% reductions.
- Oracle tools that summarise the EHR before outpatient visits are being phased in, with inpatient use to follow.
- A year into the Cleveland Clinic cancer affiliation, he calls it "phenomenal"; it helps recruit talent (two surgical oncologists) and keep patients from going to Philadelphia hospitals.
- Main campus expansion: new cardiac tower, emergency department and post-acute rehabilitation center; medical school plans with Drexel and Stockton University.
- About 40% of patients rely on Medicaid; he worries about looming Medicaid reductions and says "the funding mechanism for all of health care is broken".

### [Hospital CEO Roundtable 2025 (SJ Magazine)](https://sjmagazine.net/featured/hospital-ceo-roundtable-2025)

Executive talk · Michael Charlton, President and CEO · 2025-12-01

- SJ Magazine's Hospital CEO Roundtable 2025 (published December 1, 2025) gathered six South Jersey health-system CEOs, including AtlantiCare's Michael Charlton; this summary covers his answers.
- He calls AtlantiCare's "biggest secret weapon" its ownership of a federally qualified health center (FQHC), which brings extra payments for Medicaid and uninsured patients and funds primary, specialty and behavioral care plus social-needs services.
- The new medical school is expected to be ready in January 2029 and will be "a game changer" for AtlantiCare and Atlantic City's economy.
- The Cleveland Clinic oncology affiliation gives access to its procedures, protocols and tumor boards; the cancer program is "really world class now".
- On AI he is deliberately cautious: AtlantiCare told its board it will not be a first mover but "a quick second mover"; he flags bias in training data.
- Medicaid cuts worry him because a large portion of the Atlantic City primary service area is on Medicaid.
- AtlantiCare University trains staff where there are shortages; medical-assistant shortages are solved, nursing shortages are "no longer a challenge" and first-year nurse retention is 98%.

## Questions about AtlantiCare

### What does AtlantiCare do?

AtlantiCare is a non-profit integrated health system in southeastern New Jersey. It runs AtlantiCare Regional Medical Center (593 licensed beds), a physician group, behavioral health services, ambulatory surgery centers, a captive insurer and an accountable care organization.

### What is AtlantiCare's revenue?

Total revenue was $1,318.7 million in FY2025 (2024: $1,238.5 million), with net patient service revenue of $1,260.5 million and operating income of $7.6 million.

### Who leads AtlantiCare?

Michael Charlton has been President and CEO since October 2023, after serving on the board for 15 years.

### What is AtlantiCare's strategy?

Vision 2030 combines an Oracle IT overhaul, a Cleveland Clinic cancer affiliation, a new medical school expected in January 2029 and a main-campus expansion with a cardiac tower, emergency department and rehabilitation center.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
